In eight of the ten cell lines, there is a tendency for RUNX2 to increase rather than decrease the expression of genes, in the adenocarcinoma cell line, ACHN, expression changes are not correlated with each other, and in the neuroblastoma line, IMR-32, RUNX2 expression tends to decrease the expression of genes. This evidence concerns the gene RUNX2 and neuroblastoma.